NNRX (NNRX) Stock Price & Analysis
NNRX (NNRX) rose 0.00% to USD 0 as of June 10, 2026 at 05:25 UTC, according to Nexqual real-time market data.
NNRX last closed at USD 0; the session ranged USD 0–0 on volume of 300,000 shares. Market capitalization is $816,232, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 05:25 UTC.
Key Statistics (as of June 10, 2026 at 05:25 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 300,000 shares |
| Market Cap | $816,232 |
| Exchange | PNK |
Technical Analysis (NNRX)
Nexqual's technical model rates NNRX "SELL" based on 0 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 05:25 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Above (USD 0) |
Analyst Ratings (NNRX)
Wall Street analysts rate NNRX "None", per Nexqual as of June 10, 2026 at 05:25 UTC.
| Consensus Rating | None |
|---|
Earnings (NNRX)
Source: Nexqual, June 10, 2026 at 05:25 UTC.
Financials & Fundamentals (NNRX)
| Total Revenue | $0 |
|---|---|
| Gross Margin | +0.00% |
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0 |
| Total Cash | $34 |
| Total Debt | $3.45M |
Source: Nexqual, June 10, 2026 at 05:25 UTC.
Financial Health Score (NNRX)
Nexqual rates NNRX's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 05:25 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $34 cash vs $3M debt |
| Cash Flow | Solid — Operating cash flow $4K |
| Efficiency | Mixed — No data |
Ownership (NNRX)
| Insider Ownership | +7.43% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 16.32B |
| Float | 4.19B |
Source: Nexqual, June 10, 2026 at 05:25 UTC.
Leadership (NNRX)
NNRX is led by Jonathan Bishop, CEO & Member of Advisory Board, per Nexqual as of June 10, 2026 at 05:25 UTC.
| CEO & Member of Advisory Board | Jonathan Bishop |
|---|---|
| President & Chief Revenue Officer | Geoffrey Bazegian |
| Senior Vice President of Agricultural Supply Chain | Neil Zoller |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FONU | FONU2 INC | USD 0 | ▲ 0% |
| GNCP | GNCC CAPITAL INC | USD 0 | ▲ 0% |
| HVCW | HARRISON VICKERS & WATERMAN INC | USD 0 | ▲ 0% |
| NOUV | Nouveau Life Pharmaceuticals, I | USD 0 | ▲ 0% |
| DRNK | NoHo, Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:25 UTC. This page is informational and not investment advice.